Back
Adaptimmune Therapeutics PLC Vs. Bicycle Therapeutics PLC Industry Stock Comparison
Sell
20
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.80
Seasonality Move:
35.83%
Sell
28
BCYC
Bicycle Therapeutics PLC
Last Price:
23.44
Seasonality Move:
20.77%
Sell
20
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.82. The Score for ADAP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
28
Bicycle Therapeutics PLC (BCYC)
is a Sell
Is Bicycle Therapeutics PLC a Buy, Sell or Hold?
- The current Bicycle Therapeutics PLC [BCYC] share price is $24.37. The Score for BCYC is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- BCYC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.82
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.
BCYC Stock Price Chart
What is Bicycle Therapeutics PLC's stock price today?
-
The Bicycle Therapeutics PLC share price today is $24.37
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCYC is experiencing selling pressure, which indicates risk of future bearish movement.
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 48.62 | Sell |
| Chaikin Money Flow: | 454670 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.75 - 0.87) | Buy |
| Bollinger Bands (100): | (0.86 - 1.2) | Sell |
BCYC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 49.19 | Sell |
| Chaikin Money Flow: | -106000 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.59 - 26.23) | Sell |
| Bollinger Bands (100): | (21.36 - 25.28) | Buy |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.8 | Buy |
| 20-day SMA: | 0.8 | Buy |
| 50-day SMA: | 0.92 | Sell |
| 200-day SMA: | 1.13 | Sell |
| 8-day EMA: | 0.8 | Buy |
| 20-day EMA: | 0.81 | Buy |
| 50-day EMA: | 0.9 | Sell |
| 200-day EMA: | 1.03 | Sell |
BCYC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.85 | Buy |
| 20-day SMA: | 24.98 | Sell |
| 50-day SMA: | 24.33 | Buy |
| 200-day SMA: | 23.01 | Buy |
| 8-day EMA: | 24.27 | Buy |
| 20-day EMA: | 24.42 | Sell |
| 50-day EMA: | 24.22 | Buy |
| 200-day EMA: | 22.97 | Buy |
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.
Bicycle Therapeutics PLC Earnings Growth & BCYC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.07 per share, and a decrease next year of $0.45 per share.
Adaptimmune Therapeutics PLC Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bicycle Therapeutics PLC Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||